Literature DB >> 4118558

Controlled trial of exchange-transfusion therapy in fulminant hepatitis.

A G Redeker, H S Yamahiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4118558     DOI： 10.1016/s0140-6736(73)91220-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

Review 1.  Extracorporeal perfusion for the treatment of acute liver failure.

Authors:  H B Stockmann; C A Hiemstra; R L Marquet; J N IJzermans
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

Review 2.  Clinical applications of the continuous flow blood separator machine.

Authors:  C J Oon; J R Hobbs
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

Review 3.  [Liver replacement therapy. Reliable indications in acute liver failure].

Authors:  K Rifai; M Ott; M M Bahr; A Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 4.  Artificial and bioartificial support systems for liver failure.

Authors:  J P Liu; L L Gluud; B Als-Nielsen; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

5.  Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system.

Authors:  Pi-Qi Zhou; Shao-Ping Zheng; Min Yu; Sheng-Song He; Zhi-Hong Weng
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

6.  Liver transplantation for fulminant hepatic failure.

Authors:  S Iwatsuki; A C Stieber; J W Marsh; A G Tzakis; S Todo; B Koneru; L Makowka; R D Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

7.  A dog model for acetaminophen-induced fulminant hepatic failure.

Authors:  A Francavilla; L Makowka; L Polimeno; M Barone; J Demetris; J Prelich; D H Van Thiel; T E Starzl
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

8.  Total body wash-out in patients with fulminant hepatitis.

Authors:  G G Balestrieri; G Manzillo; N Spampinato; R Tufano
Journal:  Infection       Date:  1977       Impact factor: 3.553

9.  Development of a hybrid bioartificial liver.

Authors:  J Rozga; M D Holzman; M S Ro; D W Griffin; D F Neuzil; T Giorgio; A D Moscioni; A A Demetriou
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

10.  Halothane hepatitis with renal failure treated with hemodialysis and exchange transfusion.

Authors:  M Ishikawa; M M Popovtzer; S Iwatsuki; T Johansen; T E Starzl
Journal:  Jpn J Surg       Date:  1974-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.